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1254Abstract
Objective Risk‐reducing procedures can be offered to people at increased cancer risk, but many
procedures can have iatrogenic effects. People therefore need to weigh risks associated with both
cancer and the risk‐reduction procedure in their decisions. By reviewing relevant literature on breast
cancer (BC) risk reduction, we aimed to understand howwomen at relatively high risk of BC perceive
their risk and how their risk perceptions influence their decisions about risk reduction.
Methods Synthesis of 15 qualitative studies obtained from systematic searches of SCOPUS,
Web of Knowledge, PsychINFO, and Medline electronic databases (inception‐June 2015).
Results Women did not think about risk probabilistically. Instead, they allocated themselves
to broad risk categories, typically influenced by their own or familial experiences of BC. In decid-
ing about risk‐reduction procedures, some women reported weighing the risks and benefits, but
papers did not describe how they did so. For many women, however, an overriding wish to
reduce intense worry about BC led them to choose aggressive risk‐reducing procedures without
such deliberation.
Conclusions Reasoning that categorisation is a fundamental aspect of risk perception, we
argue that patients can be encouraged to develop more nuanced and accurate categorisations
of their own risk through their interactions with clinicians. Empirically‐based ethical reflection is
required to determine whether and when it is appropriate to provide risk‐reduction procedures
to alleviate worry.
KEYWORDS
breast cancer, meta‐synthesis, qualitative research, risk perception, risk reduction1 | BACKGROUND
The development of technologies to identify and protect individuals at
high risk of cancer or its recurrence is an area of continuing medical
advance.1–4 However, risk‐reducing procedures are often invasive
and carry iatrogenic risk. For patients to make informed decisions
about risk reduction, they therefore should understand and weigh risks
of disease and the long and short‐term risks and benefits associated
with different treatments.5e Creative Commons Attribution Li
by John Wiley & Sons Ltd.
wileyonlinelibrary.com/journal/ponBreast cancer (BC) risk reduction focuses the need to weigh risks
and benefits acutely, because informed estimates of BC risk are avail-
able and risk‐reduction treatments are effective but carry risks.6
Women with high BC risk can be identified from family history, with
the latter often mediated by identified gene mutations.5 Mutations in
BRCA 1 or 2 genes and a history of affected first‐degree relatives con-
fer an 80% to 90% lifetime risk, whilst mutations of other genes carry
lower risks.6 Ashkenazi, Icelandic, Swedish, Hungarian, and French‐
Canadian populations have higher rates of mutations.7 Previous BCcense, which permits use, distribution and reproduction in any medium, provided
Psycho‐Oncology. 2017;26:1254–1262.
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reduction procedures are available, with well‐understood risks and
benefits. Screening, using radiographic mammography, ultrasound, or
magnetic resonance imaging,8 cannot prevent cancer but enables early
detection, which improves prognosis. However, screening can miss
cancers, and false positive results cause unnecessary alarm.9 Chemo-
prevention, through selective estrogen receptor modulators or aroma-
tase inhibitors,10,11 can reduce incidence of estrogen receptor positive
and negative cancer in postmenopausal women.12 Selective estrogen
receptor modulators increase risk of endometrial cancer, thromboem-
bolic events and menstrual and skin complaints, and aromatase inhibi-
tors may reduce bone growth and contribute to infertility and liver
and kidney dysfunction.13 Risk‐reducing mastectomy (RRM) can
improve life expectancy in women with BRCA mutations. In lower risk
BC survivors, RRMmay reduce risk of new BC but has not been shown
to improve life expectancy because it cannot reduce the likelihood of
metastatic disease.14 Risk‐reducing mastectomy is irreversible, carries
surgical risks, may require follow‐up surgery, and can cause physical
discomfort and emotional distress linked to breast appearance and feel-
ings of damaged femininity.15,16 Bilateral salpingo‐oophorectomy
(surgical removal of the ovaries and fallopian tubes) can reduce the risk
of BC by up to 50% and risk of ovarian cancer by 90% to 95%, although
the extent of BC risk reduction has recently been questioned.17 Oopho-
rectomy is irreversible, risks surgical complications, and causes infertil-
ity and premature menopause.17,18 Therefore, women at high risk of BC
face complex choices about risk mitigation. Practitioners caring for
women face corresponding challenges around how to help women
weigh risks and benefits in making risk‐reducing decisions.
According to early “likelihood‐value” theories of decision making,
people should weigh risks and benefits of different decision options
by estimating the likelihood and personal value of potential outcomes
and select the option that offers the optimal combination of these.19,20
However, people do not, in practice, report thinking about risk in con-
tinuous estimates of likelihood and value21,22 and measures of these
poorly predict behaviour.23,24 The evidence suggests, instead, that
people base risk perceptions and associated decisions on mental heu-
ristics, ie, “rules of thumb” or approximations that allow easier decision
making.24 Examples are the “affect heuristic,” whereby people's
inferences of risk are guided by their emotional feelings, and the “avail-
ability heuristic,” whereby people infer risk from the ease with which
risk‐related information can be recalled.25
Whilst heuristics can reduce the extent to which people contem-
plate objective risks and logically integrate them into decision making,
they might also improve decisions by allowing people to respond to
complex information that they would otherwise be unable to assimi-
late in a more rational way.26 A large and diverse range of heuristics
have been documented, but many are specific to the demands and
contexts of particular decisions.27 Thus, women's risk perception and
decision making in BC risk reduction cannot be understood through
merely appreciating that they use heuristics but requires detailed
understanding of the heuristics they use and the influence of these
on decision making. We are aware of no work that reviews this evi-
dence in BC risk reduction, and this was the aim of the present study.
The measurement procedures of quantitative research in this context
necessarily presuppose the main ways in which risk perception anddecision making vary. Consistent with our inductive aim, we therefore
focused on qualitative research. Our specific aims were, first, to syn-
thesise qualitative literature concerning how women with elevated risk
for BC perceive risk and how these perceptions influence decision
making about risk reduction and, second, to draw implications for
how clinicians can help women make these decisions.2 | METHODS
2.1 | Inclusion and exclusion criteria
We included peer‐reviewed qualitative studies that examined risk per-
ception or decision making in adult women at high risk for BC. We
used a broad definition of risk perception as “an individual's personal
understandings of BC risk and of the risks and benefits of risk‐reduc-
tion options.” Higher risk groups included women with established
genetic mutations (eg, BRCA 1/2), or familial risk factors (affected
first‐degree relatives), higher scorers on predictive scales derived from
epidemiologic analyses of risk factors, members of ethnic populations
characterized by higher risk, and women who had previously been
examined with BC. Studies of women currently under treatment for
BC were excluded. Inclusion was limited to English language reports.
Databases (see below) were searched from inception to June 2015.2.2 | Search strategy
Search terms and alternatives were initially identified using several
reviews relevant to this area22,23 and then augmented by scoping
searches. Terms in the title, abstract, or keywords relevant to BC
(“breast cancer” or “breast carcinoma” or “breast neoplasm”) and risk
perception (“risk perception” or “risk understanding” or “perceived risk”
or worry or dread or “anticipated emotion” or “anticipatory emotion” or
emotion* or vulnerability) and qualitative methodology (qualitative or
“Grounded theory” or IPA or “interpretative phenomenological analy-
sis” or “thematic analysis” or “content analysis” or “narrative Analysis”
or “conversation analysis” or “discourse analysis” or interview* or
“focus groups”) were searched.
The electronic databases PsycINFO (1879‐2015), Medline (1948‐
2015), Web of Knowledge (1900‐2015), and Scopus (1960‐2015) were
searched. Reference lists from previous systematic reviews were also
searched. Searches were combined, and duplicates removed before
study selection. Hand searches were also conducted of the reference
lists of the included articles.2.3 | Study selection
Using the electronic databases, search terms were identified from
titles, abstracts, and keywords. Following the search, identified studies
were assessed for inclusion. Initially, HGF screened all identified titles
and then the abstracts of selected titles for potential inclusion. Then all
papers identified as potentially relevant were read by HGF who
assessed whether they met the inclusion criteria. When this was
unclear, SLB also read the study and a joint decision was reached.
Stage of exclusion and the reasons for exclusion were recorded
(Table 1). Figure 1 describes study selection using the Preferred
TABLE 1 Reasons for exclusion of studies by stage of selection
Title
Screening
Abstract
Screening
Full Text
Screening
Sample (eg, not a high risk sample) 282 380 29
Topic (eg, not about risk perception) 0 423 57
Method (eg, not qualitative) 3 183 6
Study type (eg, not primary data—
review or commentary)
1 27 12
Duplicate not previously identified 28 9 2
1256 FIELDEN ET AL.Reporting Items for Systematic reviews and Meta‐Analysis28 flow
diagram.2.4 | Data synthesis
Wewanted to develop new theoretical insights, grounded in the findings
of individual studies but with general applicability across those studies
and, therefore, potentially beyond them. Thus, we took an inductive
approach, drawing upon grounded formal theory.29,30 This approach
starts with a descriptive analysis of data from the reviewed studies
(including the research question, sample description, inductive catego-
ries arising from the authors' analysis, and the illustrative data
contained in the reports) but then progresses to a theoretical analysis.
The key method of analysis is constant comparison within and across
studies to detect convergences and resolve inconsistencies. Our syn-
thesis was at the level of reported findings rather than the authors'
interpretations, and we sometimes drew different theoretical conclu-
sions from the authors in the context of the developing analysis. HGF
peformed a preliminary synthesis, first developing a descriptive analysisthen a theoretical integration of this analysis. Then HGF and SLB inter-
rogated this to identify consistencies and inconsistencies with the
source data, and SLB provided a reformulated model. SLB and HGF
then compared the reformulated model to the preliminary synthesis.
The final synthesis arose through discussion amongst all authors.3 | RESULTS
Table 2 summarises31–47 the 17 included studies, each based on a unique
sample. Countries of origin were the United States, the United Kingdom,
Canada, Australia, Israel, and the Netherlands. Sample sizes ranged from
17 to 123 (median 30, total 629). There was no overlap in samples
between the studies. Six studies examined populations of women mainly
defined by familial risk, 3 examined women with known genetic muta-
tions (all had affected family members), 3 identified women by high
scores on multivariate risk estimation tools (again, many women had
affected family members), and 2 were studies of BC survivors.3.1 | Overview
Women generally perceived risk categorically rather than probabilisti-
cally, partly based on previous family experiences of BC. Decisions
about risk reduction arose in 2 very different ways, depending on
how intensely women worried about BC.3.2 | Women did not perceive risk probabilistically
Only 3 of the 16 studies reported evidence that women viewed risk in
likelihood‐value terms. Of these, only Robertson31 reported thatFIGURE 1 Preferred Reporting Items for
Systematic reviews and Meta‐Analysis flow
diagram of article selection process
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FIELDEN ET AL. 1259women made probabilistic risk estimates. In this study, many women
spontaneously attempted to create their own personal risk estimate,
anchoring this in a known population average and adjusting their esti-
mate according to their personal risk factors. Robertson studied
women with elevated Gail risk factor scores but excluded any who
had experienced cancer or had been referred for a genetic test. Thus,
her sample may have a lower risk profile than other reviewed studies,
which might explain her unique finding that women commonly used
probabilistic risk perceptions. The other 2 studies reporting probabilis-
tic estimates found these in only a few women. When asked to
describe personal risk, only 2 of 24 women in Keogh et al32 study of
women at familial risk volunteered what could be regarded as continu-
ous estimates (eg, “one in three”). Beesley et al33 found, amongst 60
BC survivors requesting contralateral RRM, only 5 reported probabilis-
tic estimates. Indeed, several studies showed that a proportion of
women explicitly rejected the notion of trying to understand risk prob-
abilistically or using objective risk estimates.33,343.3 | Women perceived risk categorically
Instead, when asked to describe personal risk, most women used ver-
bal labels to describe risk categories to which they felt they
belonged.34–39 Categorisation was pervasive across the differing sam-
ples and analysis methods, and women were explicit about doing this.
Category labels were diverse. Some, such as “probable,” “high risk,” or
certain (of BC) could be seen as ordinal points across a spectrum of
likelihood.34,38,39 Others described positions relative to population
risk, such as “a bit higher than population “risk” or “no higher than any-
one else.”34,36,39 Other labels encompassed qualitative categories such
as “vulnerable” or “at risk.”39 Categorisations were generally realistic.
Almost all women acknowledged being at high risk in either an abso-
lute sense or comparison with the wider population, and 1 study
showed that women's self‐categorisations were largely consistent with
the categorical estimates that they had been given by professionals.38
Women were explicit about the ways that they developed these
categories and about using category labels to help them to think about
risk. Some spontaneously assigned themselves to categories, based on
either their personal or their family experiences related to cancer (see
below), their theories about specific risk factors,32,34 or their emotional
responses to risk.34 Others reported that health professionals intro-
duced them to the categories that they used.33,39 In 1 study,38
BRCA1/2 mutation carriers wanted health professionals to provide
them with risk “labels.”3.4 | Family experiences defined risk perceptions
Women's perceived risk categories were informed by family
experiences of BC.34,35,39 Some women were explicit about how their
family histories led them to believe that they were in a high risk cate-
gory.39–41 However, in most women, the influence of family experi-
ences was implicit.33,39–43 Women assumed that their futures would
follow the path of a family member's illness with little consideration
that their own cancer likelihoods or experiences might differ.35,39–42
The ages, sites, and stages at which relatives had been examined and
the outcomes of relatives' illnesses defined expectations of their ownfates, in that they expected to have cancers that would develop with
the same trajectories [34,41,42]. Relatives' ages were particularly impor-
tant. Dagan and Goldblatt41 referred to this as the “family clock,”
Werner‐Lin40 as a “danger zone.” Remaining healthy at the age at
which their mothers developed BC provided hope for future health,41
and women felt profound relief when these landmarks had
passed.34,36,41 Thus, memories of the experiences themselves consti-
tuted risk perceptions by implicitly defining templates of expectations
about personal futures. The dominance of family experiences in
shaping risk perceptions was not, however, inevitable. Chalmers and
Thomson35 showed that some women moved away from an experi-
ence‐determined view of BC risk toward more nuanced and objec-
tively based understandings over time. These women sought
objective information about risk, reflected upon this and integrated it
into their views of risk.
Family experiences sometimes led to a sense of inevitability about
BC, inducing a “labelling” error whereby BC risk was described as
“certain.” This was evident in those whose mothers had been examined
with BC44 and in some with affected first or second‐degree rela-
tives.32,35 After positive BRCA tests, many women in Werner‐Lin40
study felt that they were on a “path towards cancer.”3.5 | Some women deliberated about risk, but worry
impelled others toward aggressive risk‐reduction
procedures
Womenmade decisions in 2 ways, largely depending upon their level of
worry. Where worry was not intense, women generally reported
weighing their risk of BC and iatrogenic risks associated with
risk‐reduction procedures. They also considered other factors, such as
how engaging in research might help other women,34 how future child-
bearing and breast‐feeding aspirations might militate against oophorec-
tomy or RRM, and how current parental responsibilities militated
against any such major surgery.35,39–41 Sometimes they postponed
decisions if they felt unready to make them.37 Unfortunately, the
reviewed studies did not reveal howwomenmade comparisons between
different risks to make their decisions. Therefore, whilst we know that
women largely thought about risk categorically, we do not know how
they weighed different risks in reaching decisions. Nonetheless, women
who weighed risks and benefits were generally content with their deci-
sions.37,41–43 Often the decisions provoked strong emotions, but women
did not describe these emotions as influencing their decisions.44,45
Each study described women whose decisions were shaped by
intense levels of worry about BC. Women described fears about BC
as ever‐present, intrusive, uncontrollable, and sometimes “intolera-
ble.”31,32,36,41 The threat of BC was a “constant companion” for these
women31,40 and induced a persisting sense of threat.44 No study
explicitly examined why these women worried so intensely, and worry
was not clearly explained by the risk category to which women allo-
cated themselves. Whilst some women attributed worry to being in a
high risk “category” or to recalling salient family experiences of
BC,33,36–38 women who saw themselves as at high risk did not all
worry so intensely.32,34 Believing that cancer was inevitable could
even reduce worry where women with family history of BC resigned
themselves to this.39,45
1260 FIELDEN ET AL.Worry resisted reassurance from professionals' descriptions of
objective risk or from good outcomes of clinical investigations.32,34,37
Instead, minimising worry became the overriding and urgent goal that
women pursued through their decisions about risk reduc-
tion.32,33,36,41–43,46,47 Women acknowledged that they were more
worried than their objective risk warranted, but their decisions were
nonetheless determined by worry.33,38,46 The goal of minimising worry
typically led women to eschew conservative options and choose the
most aggressive available to them. Worry led women to prefer mam-
mographic screening to self‐care such as breast self‐examination,46
participation in a chemoprevention trial to screening,36 and RRM to
screening.33,44 Many described needing to “do something” and feared
missing opportunities to reduce risk, but there was little indication that
women had closely considered the iatrogenic risks associated with
their chosen procedures, particularly RRM or
oophorectomy.31,32,34,42,43,454 | DISCUSSION
Women did not generally think probabilistically about risk. Instead,
they perceived risk in idiographic categorisations, influenced by family
experiences. Some women deliberated about their decisions, whereby
they weighed risks and benefits of different options. For others, worry
excluded deliberation and drove choices of aggressive risk‐reducing
options.
Seen from the perspective of research showing that categorisation
introduces error into risk‐related health decision making, the central
role of categorisation in women's perception of risk is potentially
alarming. For example, Cameron et al48 showed that the categorisation
of probabilistic risk estimates inevitably reduces accuracy by dividing a
linear dimension into a restricted set of categories, Thus,
miscategorisation can lead to incorrect inferences drawn from cate-
gory labels. Reyna et al49 showed that dependence on categories pre-
vents people from acting upon category‐inconsistent information. In
our review, 1 potentially major source of error in categorical risk per-
ceptions was that women inferred their risk category from memories
of family experiences. Many categorised risk as certain or saw them-
selves on an inevitable “path toward cancer.” These perceptions arose
inductively, and women did not objectively assess the significance of
family experiences. Family BC history does, in general, increase per-
sonal risk,6 but valid inferences should take account of the number
of affected relatives and their ages and their genetic relationship to
the individual. Women in the studies that we reviewed were influ-
enced mainly by aspects of the familial experience unrelated to risk,
such as the quality of family relationships and specific details of rela-
tives' experiences.
However, wider research in social psychology shows
categorisation to be a fundamental aspect of how people interpret
information and use it to make decisions.50,51 Categorisation is a heu-
ristic that allows people to remember, retrieve, and use risk informa-
tion more easily.52 Thus, category labels such as “above average” or
“at risk” provided easily accessible meanings that could help women
to make decisions. Although categorisation of risk could be biased by
family history, women wanted to use accurate categories. In particular,they sought accurate categorical information from health profes-
sionals43 and were able to remember these when later asked.38 There-
fore, categorisation should not be regarded as an inherently inaccurate
way for women to perceive risk.
Unfortunately, the reviewed studies did not illuminate how
women compared different risks to make their decisions. Unlike prob-
abilistic risk perceptions, where a common metric allows comparison of
different outcome probabilities, categories used by women in the
reviewed studies carry unique meanings that do not offer a common
metric.48 For example, patients considering surgery may use different
types of category to describe risk of BC (eg, “I am vulnerable”) and sur-
gery (eg, “I am at moderate risk”). One possibility suggested by the
broader psychological literature is that some risk categories, such as
feeling “vulnerable,” carry stronger emotional connotations than
others, such as having “moderate” risk. The risk associated with the
stronger emotional connotation might therefore drive the decision.27
Research is needed to elucidate how women compare categorical risk
perceptions in decisions about risk reduction.
The clearest evidence about decision making in the reviewed
papers arose where it was influenced by worry. Where worry was
intense, women did not consider risks and benefits. Instead, they chose
aggressive risk reduction to reduce worry, and they paid little attention
to iatrogenic risk. That is, worry “hijacked” decision making. At first
sight, this is consistent with evidence for widespread use of a heuristic
whereby people infer risk from their emotional responses.53,54 How-
ever, our review emphasised another mechanism: that worry reduction
became a decision‐making goal in its own right. That is, women pur-
sued an “emotion‐focussed” coping strategy where they sought to
reduce worry and were largely unconcerned with objective risk.54,554.1 | Practice and research implications
Our findings point to 2 challenges for practitioners working with
women who are deciding about BC risk reduction. First, women's cat-
egorical perceptions of risk may not closely correspond to objective
risk, and second, worry might hijack their decision making by leading
women to choose invasive procedures to reduce worry whilst
disregarding objective risks and benefits.
Risk perception research shows that categorisations and other
heuristics that people use to perceive risk are not static but evolve
toward greater nuance and accuracy if people engage with external
evidence.24 Our review shows that women sought accuracy in their
categorisations and formed more nuanced categories over time by
seeking information about the categories to which they belonged from
health professionals.38 Relevant information does not necessarily have
to be presented didactically, and indeed, didactic presentations may be
counterproductive.56 Street56 and Elwyn et al57 both emphasise the
centrality of patient‐clinician dialogue in enhancing the extent to
which patients are able to make well‐informed decisions based on risks
and benefits; it allows clinicians to assess patients' understanding and
tailor information to patients' needs, and patients to test and improve
their understanding based on clinicians' feedback. Thus, effective con-
sultation with women considering risk reduction does not merely
extend to providing information about risk but involves clinicians
eliciting and shaping women's own idiographic categorisations of risk.
FIELDEN ET AL. 1261The influence of worry is harder to address. Where it is linked to
perceiving oneself to be at high risk of BC, worry might be alleviated
by helping women to question the risk perceptions that they have
formed, as we describe above. However, cancer worry is not simply a
product of high‐risk perceptions and indeed appears to be largely
insensitive to reassurance about risk.54 It is partly a consequence of
unrelated factors, including general emotional state, negative life expe-
riences, and stressful or unsupportive environments.58 Whilst counsel-
ing or other interventions for worry might therefore prove helpful in
some instances, it is unrealistic to expect that worry can be completely
banished in clinical contexts in which patients are faced with the mor-
tal threat of serious illness. Therefore, particularly when the clinical
benefits of interventions are unclear, clinicians will face the dilemma
of how to reconcile the normative expectations for them to respect
patients' requests, motivated by escape from worry, whilst simulta-
neously meeting their needs, which go beyond worry to encompass
the balance between reduction of BC risk and avoidance of iatrogenic
harm. The dilemma hinges on the ethical question as to whether and
when it is appropriate for clinicians to provide invasive, and even sur-
gical, responses to psychological need. Ethical analyses in the fields of
cosmetic59 and bariatric surgery60 suggest surgical intervention for
psychological benefit can be justified, but that a case always needs
to be made that clinical and psychological benefits outweigh risk, that
benefits are likely to occur and that benefits cannot be achieved with
less risk.
Where solutions to ethical dilemmas cannot be derived from gen-
eral normative principles, Kleinman61 proposed that the starting point
for reflecting on possible solutions should be detailed study of how
practitioners and patients resolve these dilemmas in practice. Unfortu-
nately, the studies that we reviewed provided little insight into this.
Future research that examines, not only women's accounts but also
those of the clinicians caring for them, and which examines how deci-
sions are negotiated between them in consultations, could provide evi-
dence from which realistic and ethically robust solutions can be
derived.
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